SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BERNARDI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.099
AS - Asia 14.537
EU - Europa 9.230
SA - Sud America 2.442
AF - Africa 226
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 57.586
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.477
SG - Singapore 5.859
CN - Cina 4.349
BR - Brasile 2.075
DE - Germania 2.023
UA - Ucraina 1.734
IT - Italia 1.592
HK - Hong Kong 1.422
TR - Turchia 1.082
GB - Regno Unito 949
VN - Vietnam 809
FI - Finlandia 596
PL - Polonia 538
SE - Svezia 481
RU - Federazione Russa 469
CA - Canada 290
MX - Messico 271
ID - Indonesia 225
FR - Francia 203
IN - India 194
AR - Argentina 150
NL - Olanda 126
JP - Giappone 119
ZA - Sudafrica 113
BE - Belgio 103
ES - Italia 101
BD - Bangladesh 96
CZ - Repubblica Ceca 63
EC - Ecuador 63
IQ - Iraq 53
LT - Lituania 48
AT - Austria 47
IR - Iran 40
UZ - Uzbekistan 35
CO - Colombia 34
MA - Marocco 30
PK - Pakistan 29
VE - Venezuela 28
AU - Australia 26
CH - Svizzera 24
CL - Cile 23
PE - Perù 23
IL - Israele 21
PY - Paraguay 21
IE - Irlanda 20
KE - Kenya 19
MY - Malesia 19
AE - Emirati Arabi Uniti 17
JO - Giordania 17
RO - Romania 17
SA - Arabia Saudita 17
UY - Uruguay 17
TW - Taiwan 16
AZ - Azerbaigian 15
KR - Corea 14
PT - Portogallo 13
TN - Tunisia 13
AL - Albania 12
DZ - Algeria 12
EU - Europa 12
GR - Grecia 12
NP - Nepal 11
BG - Bulgaria 10
EG - Egitto 10
JM - Giamaica 10
DO - Repubblica Dominicana 9
GE - Georgia 8
HN - Honduras 7
KW - Kuwait 7
KZ - Kazakistan 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
OM - Oman 7
TH - Thailandia 7
BY - Bielorussia 6
CR - Costa Rica 6
DK - Danimarca 6
SN - Senegal 6
AF - Afghanistan, Repubblica islamica di 5
BH - Bahrain 5
BO - Bolivia 5
GT - Guatemala 5
HU - Ungheria 5
NG - Nigeria 5
PH - Filippine 5
TT - Trinidad e Tobago 5
CI - Costa d'Avorio 4
KG - Kirghizistan 4
LB - Libano 4
MK - Macedonia 4
NI - Nicaragua 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
GA - Gabon 3
KH - Cambogia 3
LK - Sri Lanka 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
Totale 57.537
Salva come PNG Salva come JPEG
Città #
Singapore 3.219
Woodbridge 2.988
Fairfield 2.928
Ashburn 2.674
Chandler 1.929
Houston 1.907
Jacksonville 1.837
Santa Clara 1.546
Beijing 1.411
Ann Arbor 1.407
Hong Kong 1.405
Seattle 1.206
Wilmington 1.110
Cambridge 962
Dallas 901
Izmir 629
Nanjing 571
New York 529
Ferrara 522
Warsaw 520
Munich 517
Los Angeles 473
Princeton 437
Boardman 402
San Diego 272
Ho Chi Minh City 271
Milan 212
Shanghai 205
The Dalles 200
São Paulo 196
Mexico City 189
Dearborn 173
Nanchang 173
Shenyang 170
Hanoi 168
Jakarta 163
Bremen 162
Helsinki 144
Tianjin 134
London 133
Buffalo 121
Hebei 120
Chicago 115
Hefei 111
Jiaxing 110
Brooklyn 108
Falls Church 104
Tokyo 101
Toronto 99
Turku 99
Changsha 98
Brussels 94
Redwood City 86
Jinan 82
Montreal 79
Falkenstein 75
Denver 74
Frankfurt am Main 73
Moscow 72
Norwalk 72
San Mateo 71
Orem 70
Johannesburg 68
Kunming 67
Rio de Janeiro 67
Mountain View 65
Chennai 63
Atlanta 59
Stockholm 58
Düsseldorf 57
Phoenix 55
Rome 55
Poplar 51
San Francisco 51
Belo Horizonte 50
Zhengzhou 50
Auburn Hills 49
Brno 48
Guangzhou 48
Nuremberg 46
Curitiba 45
Dong Ket 44
Manchester 44
Addison 42
Council Bluffs 42
Boston 41
Des Moines 41
Amsterdam 40
Ningbo 38
Hangzhou 37
Brasília 36
Columbus 34
Ankara 33
Bologna 33
Orange 31
Ottawa 30
Porto Alegre 30
Tashkent 29
Washington 29
Biên Hòa 28
Totale 38.763
Salva come PNG Salva come JPEG
Nome #
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 375
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 286
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 273
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 261
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 259
AN EXON-SPECIFIC U1 SMALL NUCLEAR RNA (snRNA) STRATEGY TO CORRECT SPLICING MUTATIONS ASSOCIATED TO HEMOPHILIA B 258
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 249
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 249
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 245
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 243
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 240
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 240
Hemostasis biomarkers in multiple sclerosis 228
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 223
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 222
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 218
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 215
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 214
A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates 213
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? 212
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 208
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 208
Characterization of a deleted Y chromosome in a male with Turner stigmata 207
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 206
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 206
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 204
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 204
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 203
A NEW DISEASE-CAUSING MUTATION IN THE GAP-RELATED DOMAIN OF THE NF1 GENE 202
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 201
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 200
Moderate alcohol intake and hemostatic and inflammatory markers in middle-aged women: a controlled study 200
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 200
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 198
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 197
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 197
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 197
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 195
Attività sulla emostasi di alcune piante della medicina tradizionale indiana 191
Chronic sleep deprivation markedly reduces coagulation factor VII expression 191
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 188
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 188
Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22.3 188
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 187
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 184
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 183
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 183
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 183
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 182
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 182
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 182
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 181
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 181
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 180
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 179
Membrane binding and anticoagulant properties of protein S natural variants 179
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 178
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 178
A unique exon specific U1snRNA rescues different haemophilia B - causing splicing-defective factor IX variants in mice 177
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 177
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 176
Evidence for an overlapping role of clock and npas2 transcription factors in liver circadian oscillators 176
c-myc oncogene alterations in human thyroid carcinomas. 175
A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the italian population 174
The dominant-negative von Willebrand factor gene deletion p.P1127-C1948delinsR: Molecular mechanism and modulation 174
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 174
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 173
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 173
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 172
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 171
A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg) 171
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 171
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 168
Circadian rhythms in mouse blood coagulation 168
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 168
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 168
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 168
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 168
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 167
Plasma levels of soluble NCAM in multiple sclerosis 167
Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime 166
PvuII RFLP inside the human estrogen receptor gene 166
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 165
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 165
Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser) 164
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 164
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 163
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 163
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 161
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 161
Performance prediction models based on anthropometric, genetic and psychological traits of Croatian sprinters 161
Partial gene deletion in a family with factor X deficiency 160
A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject 159
Correction of aberrant splicing causing haemophilia B through the combination of compensatory U1snRNAs and antisense oligonucleotides 159
Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 159
Factor VII mutant V154G models a zymogen-like form of factor VIIa 158
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 158
Taqi polymorphism at the human coagulation factor XII locus (F12) 157
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 157
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 157
Totale 19.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 277.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.782
Totale 279.403
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.465 0 0 0 0 0 500 331 627 180 801 735 291
2021/20224.434 245 482 276 246 261 178 206 211 138 344 391 1.456
2022/20234.440 488 342 109 583 726 661 211 356 543 39 244 138
2023/20242.348 203 277 110 81 166 433 65 154 59 56 64 680
2024/20259.468 266 186 817 272 1.175 920 242 468 1.492 1.197 1.356 1.077
2025/202614.552 2.588 1.191 2.610 3.726 4.020 417 0 0 0 0 0 0
Totale 58.290